- Home
- FNGR vs ATYR Comparison
FNGR vs ATYR Comparison
Compare FNGR & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FNGR | ATYR |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2M | 51.7M |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FNGR | ATYR |
|---|---|---|
| Price | $0.31 | $0.52 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $3.67 |
| AVG Volume (30 Days) | ★ 1.7M | 708.5K |
| Earning Date | 05-28-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.98 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $24,132,261.00 | $190,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.17 | $0.40 |
| 52 Week High | $2.20 | $6.50 |
Technical Indicators
Market Signals| Indicator | FNGR | ATYR |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 49.53 |
| Support Level | $0.30 | $0.46 |
| Resistance Level | $0.36 | $0.59 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 62.98 | 36.98 |
Price Performance
Historical ComparisonAbout FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company's business line includes Telecommunications Products and Services, Value Added Products and Services, Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).